Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Investigational New Drugs
|
June 8, 2001
Progress in the development of alternative pharmaceutical formulations of taxanes
B Nuijen, M Bouma, J H Schellens, et al.
Cancer Treatment Reviews
|
October 25, 2016
Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique
E Sawicki, J H M Schellens, J H Beijnen, et al.
Cancer Treatment Reviews
|
March 1, 1997
Alternative formulations of paclitaxel
J M Terwogt, B Nuijen, W W Huinink, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 1, 2016
Inherent formulation issues of kinase inhibitors
M Herbrink, J H M Schellens, J H Beijnen, et al.
Drug Development and Industrial Pharmacy
|
December 25, 2016
Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies
E Sawicki, J H M Schellens, J H Beijnen, et al.
Research Quarterly for Exercise and Sport
|
April 5, 2018
Individual Differences Influencing Immediate Effects of Internal and External Focus Instructions on Children's Motor Performance
Femke van Abswoude, Nienke B Nuijen, John van der Kamp, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 30, 2008
Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT
S G L Quaak, B Nuijen, J B A G Haanen, et al.
PDA Journal of Pharmaceutical Science and Technology
|
August 17, 2001
In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol
B Nuijen, M Bouma, C Manada, et al.
Pharmaceutical Research
|
January 25, 2007
Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis
S C van der Schoot, B Nuijen, A D R Huitema, et al.
Anti-Cancer Drugs
|
January 12, 2000
Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration
B Nuijen, M Bouma, R E Henrar, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Investigational New Drugs
|
June 8, 2001
Progress in the development of alternative pharmaceutical formulations of taxanes
B Nuijen, M Bouma, J H Schellens, et al.
Cancer Treatment Reviews
|
October 25, 2016
Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique
E Sawicki, J H M Schellens, J H Beijnen, et al.
Cancer Treatment Reviews
|
March 1, 1997
Alternative formulations of paclitaxel
J M Terwogt, B Nuijen, W W Huinink, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 1, 2016
Inherent formulation issues of kinase inhibitors
M Herbrink, J H M Schellens, J H Beijnen, et al.
Drug Development and Industrial Pharmacy
|
December 25, 2016
Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies
E Sawicki, J H M Schellens, J H Beijnen, et al.
Research Quarterly for Exercise and Sport
|
April 5, 2018
Individual Differences Influencing Immediate Effects of Internal and External Focus Instructions on Children's Motor Performance
Femke van Abswoude, Nienke B Nuijen, John van der Kamp, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 30, 2008
Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT
S G L Quaak, B Nuijen, J B A G Haanen, et al.
PDA Journal of Pharmaceutical Science and Technology
|
August 17, 2001
In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol
B Nuijen, M Bouma, C Manada, et al.
Pharmaceutical Research
|
January 25, 2007
Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis
S C van der Schoot, B Nuijen, A D R Huitema, et al.
Anti-Cancer Drugs
|
January 12, 2000
Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration
B Nuijen, M Bouma, R E Henrar, et al.
Page
of 4